Clinical trials recruiting for Kaposi Sarcoma

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
  NCT05859074 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)
  NCT06004011 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years to 39 Years · Sex: All (male and female) · 1 location
• Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
  NCT04941274 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location
• Agnostic Therapy in Rare Solid Tumors
  NCT06638931 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
  NCT05663502 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 16 locations
• Natural History Study of Kaposi Sarcoma
  NCT06375122 · Phase: Not specified · Ages: 18 Years to 120 Years · Sex: All (male and female) · 1 location
• PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
  NCT04303117 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location
• Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
  NCT04902443 · Phase: Phase 1 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location
• Precision Imaging to Evaluate Kaposi Sarcoma
  NCT06898203 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Propranolol for the Treatment of Kaposi Sarcoma in Adults
  NCT06445166 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)
  NCT07308886 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: All (male and female) · 1 location
• Trial of Ixazomib for Kaposi Sarcoma
  NCT04305691 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 11 locations

Related conditions

Trials recruiting for Kaposi Sarcoma often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Kaposi Sarcoma trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.